WebOct 21, 2024 · The mTOR inhibitor nab-sirolimus (ABI-009) may emerge as an effective and tolerable treatment in patients with gynecologic cancers with TSC1 and TSC2 mutations, … WebFeb 4, 2024 · We also found that TSC1/TSC2 mutations enhanced the expression levels of some other immune-inhibitory checkpoints, including PD-1 and TIM-3. The infiltrating CD8 …
Nab-sirolimus Under Investigation in TSC1- and TSC2-mutated …
Webment.57 Wnt-dependent activation of S6K1 requires the inhibition of GSK3 and TSC1/TSC2 activity. Inhibition of GSK3 activity by Wnt is specific and distinct from its inhibition by Akt and RSK1.94 Thus, TSC2 integrates growth, energy and Wnt signaling in coor-dinated inhibition of mTORC1 signaling, protein translation and cell growth. WebKnockdown of AKT3 in DU-145 cells with siRNAincreased the sensitivity of DU-145 cells to B-Raf inhibitor treatment. Knockdown ofTSC1 or TSC2 promoted the proliferation of PCa cells. Our observations implied thatAKT3 may be a potential therapeutic target for PCa treatment. KW - Akt3. KW - B-Raf. KW - Proliferation. KW - Prostate cancer. KW - TSC1/2 ray tracing off vs on
AKT3 promotes prostate cancer proliferation cells through …
WebIn TSC1 +/− cells, the inhibition of mTORC1 and mTORC2 by torin-1 reduced tau levels and acetylation, similar to p300 inhibition. Therefore, the function of TSC1/hamartin as key … WebAug 12, 2002 · Inhibition of S6K by TSC1–TSC2. To elucidate a mechanism of TSC1–TSC2 function in the control of cell growth, we examined the effect of TSC1–TSC2 on S6K … WebFeb 8, 2024 · An Open Label, Multicenter, Single Arm Phase II Study to Evaluate the Activity and Tolerability of the Novel mTOR Inhibitor, MLN0128 (TAK-228), in Patients With Locally … ray tracing of signed distance function grids